Biogen Inc. (NASDAQ:BIIB) will hold its 2Q20 earnings conference call with the financial community on 22nd July 2020 at 8:00 AM Eastern Time.
The conference call will be webcast live on Internet at www.biogen.com
Earnings Expectation
Biogen Inc. biotech drug manufacturer, is expected to report second quarter earnings results, before market open, on Wednesday 22nd July 2020. Analysts polled by Thomson Reuters anticipate second quarter income of $ 8.04 per share. Looking ahead, the full year income are expected at $ 32.96 per share on the revenues of $ 13943.90 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 14,000.00 million ~ $ 14,300.00 million, where as bottomline are predicted in a range of $ 31.50 ~ $ 33.50 per share
Click Here For More Historical Outlooks Of Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis.
